<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02462902</url>
  </required_header>
  <id_info>
    <org_study_id>ILBS-Cirrhosis with sepsis-01</org_study_id>
    <nct_id>NCT02462902</nct_id>
  </id_info>
  <brief_title>Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension</brief_title>
  <official_title>Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Liver and Biliary Sciences, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Liver and Biliary Sciences, India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      300 consecutive patients with cirrhosis of any aetiology admitted with features of sepsis and
      sepsis induced hypotension to the intensive care unit, the emergency department and the step
      down units of Institute of Liver and Biliary Sciences, New Delhi, who fulfil the inclusion
      criteria.

      This study will be a single centre prospective randomized comparative trial. Patients will be
      randomized into two groups. Group A will receive crystalloid, 0.9% sodium chloride solution
      (total of 30ml/kg over 30 minutes) and Group B will receive colloid, 5% albumin (250 ml over
      15 minutes).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total number of patients with MAP (Mean Arterial Pressure) â‰¥ 65</measure>
    <time_frame>3 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in lactate dynamics</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of patients with Urine output &gt;/= 0.5mL/kg/hr.</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">308</enrollment>
  <condition>Cirrhosis With Septic Shock</condition>
  <arm_group>
    <arm_group_label>5% albumin Infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(250 ml over 15 to 30 minutes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.9% sodium chloride solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.9% sodium chloride solution (total of 30ml/kg over 15 to 30 minute)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5% albumin Infusion</intervention_name>
    <description>colloid, 5% albumin (250 ml over 15 to 30 minutes).</description>
    <arm_group_label>5% albumin Infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% sodium chloride solution</intervention_name>
    <description>0.9% sodium chloride solution (total of 30ml/kg over 15 to 30 minutes)</description>
    <arm_group_label>0.9% sodium chloride solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Cirrhotic patients of any aetiology with Infection - suspected or documented and Mean
             arterial pressure less than 65 mm of Hg

        Exclusion Criteria:

          1. Cirrhosis patients in septic shock who are already on vasopressors and/or inotropes

          2. Cirrhosis patients in septic shock with structural heart disease

          3. Cirrhosis patients in septic shock with chronic renal failure/dialysis
             dependent/volume overloaded state

          4. Cirrhosis patients in shock, caused by other reasons, other than septic shock

          5. Cirrhosis patients in septic shock in whom contraindication to internal jugular or
             subclavian line insertion is present

          6. Age less than 18 years

          7. Previous episode of septic shock during the same hospital stay

          8. Pregnant or lactating women

          9. Patients in need for emergent surgical interventions

         10. Cirrhosis patients in septic shock with chronic obstructive lung disease and right
             heart failure

         11. Cirrhosis patients in septic shock with associated upper gastrointestinal bleed or
             coagulopathy related bleed with a haemoglobin of less than 8g/dL or requiring urgent
             transfusions of blood and blood products

         12. A previous adverse reaction to human albumin solution
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Liver and Biliary Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110070</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2015</study_first_submitted>
  <study_first_submitted_qc>June 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2015</study_first_posted>
  <last_update_submitted>December 29, 2015</last_update_submitted>
  <last_update_submitted_qc>December 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

